Forgot Password.
By Logging in, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Not a member? Sign Up
By Signing up, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Have an account? Log in
Back to Login? Log in
By registering in, you are agreeing to the MedSearch Global terms and condition and Privacy Policy.
Thinking of joining a study?
Register your interest
4405 results
Observational
Not Applicable
100
Jewish General Hospital
Source: clinicaltrials.gov
Interventional
Phase2
24
BI 770371
Placebo for BI 770371
Boehringer Ingelheim
Phase1
JNJ-90189892
Janssen Research & Development, LLC
10
Nerve stimulation
University of Pennsylvania
138
RCT
Pulpotomy
University of Alabama at Birmingham
500
King's College London
Phase3
80
Venous Excess Ultrasound (VEXUS)-Guided Management
Western University, Canada
350
nociceptive flexion reflex (NFR) threshold ("Paintracker", Dolosys GmbH, Berlin, Germany)
Benno Rehberg-Klug
25
Propranolol
AIDS Malignancy Consortium
35
Receive the experimental combination of drugs (chemoradiation (Oxaliplatin and Capecitabine) + PD-1 inhibitor (Tislelizumab) for 3 cycles
The Affiliated Hospital of Qingdao University